Evidence map›Paper›PMID 24379188›Full record

ArticleHypertension (Dallas, Tex. : 1979)2014

NFAT5 is protective against ischemic acute kidney injury.

Shoujin Hao, Lars Bellner, Hong Zhao, Brian B Ratliff, Zbigniew Darzynkiewicz, Carlos P Vio, Nicholas R Ferreri

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 28 citations in OpenAlex.

  1. BPGM shapes NFAT5-driven cellular responses.Cellular and molecular life sciences : CMLS · 2026
    Article
  2. Article
  3. Article
  4. TNF inhibits NKCC2 phosphorylation by a calcineurin-dependent pathway.American journal of physiology. Renal physiology · 2025
    Article
  5. Segment specific loss of NFAT5 function in the kidneys is sufficient to induce a global kidney injury like phenotype.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. TNF inhibits AQP2 expression via a miR137-dependent pathway.American journal of physiology. Renal physiology · 2024
    Article
  10. MicroRNA-195a-5p Regulates Blood Pressure by Inhibiting NKCC2A.Hypertension (Dallas, Tex. : 1979) · 2023
    Article
  11. Article
  12. Article
  13. Single-nuclear transcriptomics reveals diversity of proximal tubule cell states in a dynamic response to acute kidney injury.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. Article
  15. Regulation of NKCC2B by TNF-α in response to salt restriction.American journal of physiology. Renal physiology · 2020
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shoujin HaoDepartment of Pharmacology, New York Medical College, Valhalla, NY 10595. nick_ferreri@nymc.edu.
Lars Bellner
Hong Zhao
Brian B Ratliff
Zbigniew Darzynkiewicz
Carlos P Vio
Nicholas R Ferreri
Pontificia Universidad Católica de Chile · CL

Funding

Vasoregulatory Function of CYP2E1-Derived EicosanoidsP01HL034300 · NHLBI · NEW YORK MEDICAL COLLEGE · PI JIANG, HOULI · 1985 to 2015
$33.4M
Regulation of Renal TNF Production and FunctionR01HL085439 · NHLBI · NEW YORK MEDICAL COLLEGE · PI FERRERI, NICHOLAS R · 2008 to 2011
$1.6M
NHLBI NIH HHS HL34300NHLBI NIH HHS P01 HL034300NHLBI NIH HHS R01 HL085439
6 · The paper itself

Abstract

NFAT5 is a transcription factor that protects the kidney from hypertonic stress and also is activated by hypoxia. We hypothesized that NFAT5 mitigates the extent of renal damage induced by ischemia-reperfusion injury (IRI). Mice were subjected to IRI by unilateral clamping of the left renal pedicle for 30 minutes followed by reperfusion. After 3 hours of reperfusion, the level of NFAT5 mRNA was similar in contralateral and clamped kidneys. However, after 48 hours, NFAT5 mRNA accumulation increased ≈3-fold in both outer medulla and medullary thick ascending limb tubules. NFAT1 levels were elevated at 3 hours but did not increase further at 48 hours. Mice were then either pretreated for 72 hours with an intrarenal injection of a lentivirus short-hairpin RNA construct to silence NFAT5 (enhanced green fluorescent protein-U6-N5-ex8) or a control vector (enhanced green fluorescent protein-U6) before induction of IRI. Neutrophil gelatinase-associated lipocalin and kidney ischemia molecule-1 mRNA levels increased after IRI and further increased after knockdown of NFAT5, suggesting that silencing of NFAT5 exacerbates renal damage during IRI. In contrast, silencing of NFAT1 had no effect on the levels of neutrophil gelatinase-associated lipocalin or kidney ischemia molecule-1 mRNA. Hematoxylin and eosin staining revealed patchy denudation of renal epithelial cells and tubular dilation when NFAT5 was silenced. The number of TUNEL-positive cells in the outer and inner medulla of the clamped kidney increased nearly 2-fold after knockdown of NFAT5 and was associated with an increase in the number of caspase-3-positive cells. Collectively, the data suggest that NFAT5 is part of a protective mechanism that limits renal damage induced by IRI.

Indexed as

Gene Expression RegulationAcute Kidney InjuryAnimalsApoptosisBlotting, WesternDisease Models, AnimalKidney TubulesMaleMiceMice, Inbred C57BLReal-Time Polymerase Chain ReactionReperfusion InjuryRNA, MessengerTranscription FactorsNfat5 protein, mouseRNA, MessengerTranscription Factorsacute kidney injuryNFAT transcription factor 5reperfusion injury

Identifiers

PMID24379188
PMCPMC3945409
OpenAlexW2129454878

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.